Ketoconazole

A to Z Drug Facts

Ketoconazole

  Action
  Indications
  Contraindications
  Route/Dosage
  Interactions
  Lab Test Interferences
  Adverse Reactions
  Precautions
Patient Care Considerations
  Administration/Storage
  Assessment/Interventions
  Patient/Family Education


(KEY-toe-KOE-nuh-zole)
Nizoral
Class: Anti-infective/antifungal

 Action Impairs synthesis of ergosterol, allowing increased permeability in fungal cell membrane and leakage of cellular components.

 Indications Treatment of susceptible systemic and cutaneous fungal infections.

Topical: Seborrheic dermatitis; tinea corporis; tinea cruris; tinea pedis; tinea versicolor.

 Contraindications Fungal meningitis.

 Route/Dosage

ADULTS: PO 200 to 400 mg qd. CHILDREN > 2 YR: PO 3.3 to 6.6 mg/kg/day. Treatment may last from 1 wk to 6 mo, depending on infection. ADULTS: Topical Apply to affected and immediate surrounding area qd for 2 to 4 wk.

 Interactions

Antacids: Increased gastric pH may inhibit ketoconazole absorption; separate administration by ³ 2 hr. Benzodiazepines (eg, midazolam): Plasma levels of benzodiazepines may be increased and prolonged. Corticosteroids: Increased bioavailability and decreased clearance of corticosteroid. Cyclosporine: Increased cyclosporine concentrations. Didanosine, histamine H2-receptor antagonists (eg, cimetidine), proton pump inhibitors (eg, omeprazole): May decrease ketoconazole absorption. Dofetilide: Elevated plasma levels of dofetilide may increase the risk of life-threatening cardiac arrhythmia. Nisoldipine, protease inhibitors (eg, indinavir), tacrolimus, tolterodine: Plasma levels may be elevated by ketoconazole, increasing the risk of side effects. Rifampin: Decreased serum levels of either drug; avoid concomitant use. Theophylline: Decreased theophylline serum concentrations. Warfarin: Increased anticoagulant effect.

 Lab Test Interferences None well documented.

 Adverse Reactions

CNS: Headache; dizziness; somnolence. DERM: Pruritus; urticaria. Topical use: Severe irritation, stinging, and itching. GI: Nausea; vomiting; abdominal pain. GU: Oligospermia (with high doses); impotence; gynecomastia. HEPA: Hepatitis.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: PO: Safety and efficacy in children < 2 yr not established. Topical: Safety and efficacy not established. Anaphylaxis: Has occurred after the first dose. CN infections: Drug penetrates CSF poorly. Although high doses have sometimes been used in CNS fungal infections, this is not indicated use. Gastric acidity. Ketoconazole requires acid environment for dissolution and absorption. Hepatotoxicity: Hepatotoxicity, with rare fatalities, has occurred. Use with caution in patients receiving other potentially hepatotoxic drugs, on long-term therapy, and with a history of liver disease. Hormone levels: May lower serum testosterone or suppress adrenal corticosteroid secretion.


PATIENT CARE CONSIDERATIONS


 Administration/Storage

 Assessment/Interventions

 Patient/Family Education

Books@Ovid
Copyright
© 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts